Bahadori HR - Search Results

1

Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.

Remsing LL, Bahadori HR, Carbone GM, McGuffie EM, Catapano CV, Rohr J. Remsing LL, et al. Among authors: bahadori hr. Biochemistry. 2003 Jul 15;42(27):8313-24. doi: 10.1021/bi034091z. Biochemistry. 2003. PMID: 12846580

2

Synergistic interaction between topotecan and microtubule-interfering agents.

Bahadori HR, Green MR, Catapano CV. Bahadori HR, et al. Cancer Chemother Pharmacol. 2001 Sep;48(3):188-96. doi: 10.1007/s002800100327. Cancer Chemother Pharmacol. 2001. PMID: 11592339

3

Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.

Ogretmen B, Bahadori H, McCauley M, Boylan A, Green M, Safa AR. Ogretmen B, et al. Cancer Chemother Pharmacol. 1998;42(6):441-6. doi: 10.1007/s002800050843. Cancer Chemother Pharmacol. 1998. PMID: 9788569

4

Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines.

Bahadori HR, Rocha Lima CM, Green MR, Safa AR. Bahadori HR, et al. Anticancer Res. 1999 Nov-Dec;19(6B):5423-8. Anticancer Res. 1999. PMID: 10697572

5

Irinotecan in the management of patients with pancreatic cancer.

Green MR, Harper M, Safa A, Sherman CA, Mushtaq CM, Bahadori H, Brescia FJ, Rocha Lima CM. Green MR, et al. Oncology (Williston Park). 2000 Dec;14(12 Suppl 14):31-3. Oncology (Williston Park). 2000. PMID: 11200146 Free article. Review.

6

Co-ordinated over-expression of the MRP and gamma-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines.

Ogretmen B, Bahadori HR, McCauley MD, Boylan A, Green MR, Safa AR. Ogretmen B, et al. Among authors: bahadori hr. Int J Cancer. 1998 Mar 2;75(5):757-61. doi: 10.1002/(sici)1097-0215(19980302)75:5<757::aid-ijc15>3.0.co;2-3. Int J Cancer. 1998. PMID: 9495245

7

Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer.

Rocha Lima CM, Eckardt JR, Leong SS, Sherman CA, Perkel JA, Putman T, Safa AR, Bahadori HR, Green MR. Rocha Lima CM, et al. Among authors: bahadori hr. Semin Oncol. 1999 Oct;26(5 Suppl 16):43-50; discussion 71-2. Semin Oncol. 1999. PMID: 10585008 Review.

8

Acute disseminated encephalomyelitis following infectious mononucleosis.

Bahadori HR, Williams VC, Turner RP, Rumboldt Z, Reigart JR, Fowler SL, Chavis PS, Maria BL. Bahadori HR, et al. J Child Neurol. 2007 Mar;22(3):324-8. doi: 10.1177/0883073807300534. J Child Neurol. 2007. PMID: 17621505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters